Anthology generates diverse, designer genomes by combining genetic parts across species boundaries to create novel biological capabilities. This technology enables the scalable and efficient production of functional proteins for human nutrition, improved animal health solutions, and carbon-neutral bioproduction from waste feedstocks. The resulting designer genomes maximize the practical impact of biology in addressing major global challenges.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional biomanufacturing relies on a limited set of well-characterized organisms, restricting the diversity of products that can be produced sustainably and cost-effectively. This dependence on a narrow range of organisms limits the raw material portfolio and hinders the efficient production of many biologically derived substances.
Solution
This company employs genomic optimization and digital tools to engineer diverse genomes from underexplored organisms, such as filamentous fungi, to expand the possibilities of biomanufacturing. By harnessing the genetic potential of these organisms, the company enables the sustainable and cost-competitive production of a wider range of valuable products. This approach overcomes the limitations of traditional biomanufacturing by diversifying the raw material inputs and improving the efficiency of producing biologically derived substances. The company's platform allows for the creation of novel biochemical pathways and the optimization of existing ones, leading to improved yields and reduced production costs.
Target Audience
The primary customers are companies in the biomanufacturing sector seeking to expand their product portfolio, improve production efficiency, and adopt more sustainable practices.
Features
- Genomic optimization platform for engineering diverse genomes.
- Digital tools for streamlining the biomanufacturing process.
- Focus on underexplored organisms like filamentous fungi.
- Sustainable and cost-competitive biomanufacturing of a wider range of products.
- Expansion of the raw material portfolio for biomanufacturing.
- Improved efficiency in producing biologically derived substances.